CC-11006 - Inxight Drugs

HHS Logo U.S. Department of Health & Human Services Divider Arrow NIH Logo National Institutes of Health Divider Arrow NIH Logo NCATS ncats logo ncats logo Return Home Inxight Drugs
  • Search Substances
  • Home
  • Browse Drugs
    • US Approved Drugs
    • Marketed Drugs
    • Investigational Drugs
    • All Substances
  • Search
    • Structure Search
    • Sequence Search
  • Downloads
  • About
  • Search Substances
CC-11006 6DC9826KIM Investigational Source: NCT00458159: Phase 1 Interventional Terminated Myelodysplastic Syndrome (2007) Source URL: https://clinicaltrials.gov/ct2/show/NCT00458159 CC-11006 6DC9826KIM Investigational Source: NCT00458159: Phase 1 Interventional Terminated Myelodysplastic Syndrome (2007) Source URL: https://clinicaltrials.gov/ct2/show/NCT00458159

Details

Stereochemistry RACEMIC
Molecular Formula C18H17N3O5
Molecular Weight 355.3447
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0
SHOW SMILES / InChI Structure of CC-11006 SHOW STEREO... HIDE STEREO...
  • Structure Search

SMILES

O=C(NCC1=CC=CC2=C1C(=O)N(C3CCC(=O)NC3=O)C2=O)C4CC4

InChI

InChIKey=ZBXHNCURDISBRO-UHFFFAOYSA-N InChI=1S/C18H17N3O5/c22-13-7-6-12(16(24)20-13)21-17(25)11-3-1-2-10(14(11)18(21)26)8-19-15(23)9-4-5-9/h1-3,9,12H,4-8H2,(H,19,23)(H,20,22,24) HIDE SMILES / InChI

Approval Year

Unknown139594
Name Type Language
CC-11006 Source:
Code English
CYCLOPROPANECARBOXAMIDE, N-((2-(2,6-DIOXO-3-PIPERIDINYL)-2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL)METHYL)- Sources:
Systematic Name English
CYCLOPROPANECARBOXYLIC ACID (2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXO-2,3-DIHYDRO-1H-ISOINDOL-4-YL-METHYL)-AMIDE Source:
Systematic Name English
N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXO-2,3-DIHYDRO-1H-ISOINDOL-4-YL)METHYL)CYCLOPROPANECARBOXAMIDE Sources:
Systematic Name English
Code System Code Type Description
CAS Sources:
444287-44-9 Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 PRIMARY
NCI_THESAURUS Source:
C101370 Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 PRIMARY
CAS Source:
934481-60-4 Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 NO STRUCTURE GIVEN
FDA UNII
6DC9826KIM Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 PRIMARY
PUBCHEM Source:
10155135 Created by admin on Fri Dec 15 16:21:30 GMT 2023 , Edited by admin on Fri Dec 15 16:21:30 GMT 2023 PRIMARY
SUBSTANCE RECORD 6DC9826KIM Structure of CC-11006 CC-11006 NIH NCATS PRIVACY ACT ACCESSIBILITY DISCLAIMER HHS VULNERABILITY DISCLOSURE For language access assistance, contact the NCATS Public Information Officer National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966 version 1.1

Từ khóa » Cc-11006